22 related articles for article (PubMed ID: 38470227)
1. Enhancers of Human and Rodent Oligodendrocyte Formation Predominantly Induce Cholesterol Precursor Accumulation.
Sax JL; Hershman SN; Hubler Z; Allimuthu D; Elitt MS; Bederman I; Adams DJ
ACS Chem Biol; 2022 Aug; 17(8):2188-2200. PubMed ID: 35833657
[TBL] [Abstract][Full Text] [Related]
2. Diverse Chemical Scaffolds Enhance Oligodendrocyte Formation by Inhibiting CYP51, TM7SF2, or EBP.
Allimuthu D; Hubler Z; Najm FJ; Tang H; Bederman I; Seibel W; Tesar PJ; Adams DJ
Cell Chem Biol; 2019 Apr; 26(4):593-599.e4. PubMed ID: 30773481
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of 8,9-unsaturated sterols drives oligodendrocyte formation and remyelination.
Hubler Z; Allimuthu D; Bederman I; Elitt MS; Madhavan M; Allan KC; Shick HE; Garrison E; T Karl M; Factor DC; Nevin ZS; Sax JL; Thompson MA; Fedorov Y; Jin J; Wilson WK; Giera M; Bracher F; Miller RH; Tesar PJ; Adams DJ
Nature; 2018 Aug; 560(7718):372-376. PubMed ID: 30046109
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of SC4MOL and HSD17B7 shifts cellular sterol composition and promotes oligodendrocyte formation.
Pleshinger MJ; Friedrich RM; Hubler Z; Rivera-León AM; Gao F; Yan D; Sax JL; Srinivasan R; Bederman I; Shick HE; Tesar PJ; Adams DJ
RSC Chem Biol; 2022 Jan; 3(1):56-68. PubMed ID: 35128409
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for human sterol isomerase in cholesterol biosynthesis and multidrug recognition.
Long T; Hassan A; Thompson BM; McDonald JG; Wang J; Li X
Nat Commun; 2019 Jun; 10(1):2452. PubMed ID: 31165728
[TBL] [Abstract][Full Text] [Related]
6. The landscape of targets and lead molecules for remyelination.
Caprariello AV; Adams DJ
Nat Chem Biol; 2022 Sep; 18(9):925-933. PubMed ID: 35995862
[TBL] [Abstract][Full Text] [Related]
7. Progress in the development of beta-secretase inhibitors for Alzheimer's disease.
Albert JS
Prog Med Chem; 2009; 48():133-61. PubMed ID: 21544959
[TBL] [Abstract][Full Text] [Related]
8. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
Meanwell NA
Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149
[TBL] [Abstract][Full Text] [Related]
9. Discovery and Optimization of Selective Brain-Penetrant EBP Inhibitors that Enhance Oligodendrocyte Formation.
Dorel R; Sun D; Carruthers N; Castanedo GM; Ung PM; Factor DC; Li T; Baumann H; Janota D; Pang J; Salphati L; Meklemburg R; Korman AJ; Harper HE; Stubblefield S; Payandeh J; McHugh D; Lang BT; Tesar PJ; Dere E; Masureel M; Adams DJ; Volgraf M; Braun MG
J Med Chem; 2024 Mar; 67(6):4819-4832. PubMed ID: 38470227
[TBL] [Abstract][Full Text] [Related]
10. [Mechanisms underlying remyelination with special focus on demyelination models of multiple sclerosis].
Zheng S; Zhao J
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 49(4):524-530. PubMed ID: 32985167
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
